Maosheng Fertility Center (Lee Women's Hospital)

Maosheng Fertility Center (Lee Women’s Hospital) — IVF in Taichung & New Taipei, Taiwan

About Maosheng Fertility Center

Maosheng Fertility Center is the assisted-reproduction division of Lee Women’s Hospital (Maosheng Hospital), a fertility-specialty hospital in Taichung, Taiwan. The institution’s roots go back to 1987, when founder Prof. Lee Mao-Sheng led the team at Zhong-Shan Medical University Hospital that delivered Taiwan’s first test-tube baby completed entirely by a local medical team. The practice evolved into a clinic in 1994 and was upgraded to Lee Women’s Hospital in December 2015, passing the Taiwan Ministry of Health and Welfare hospital accreditation in 2016. A second campus in Banqiao (New Taipei City) opened in 2024, and a Zhubei branch near the Hsinchu Science Park is under construction.

The center reports more than 40,000 babies born through its program for families from 38 countries (official hospital figures). On its annual-milestones page the hospital cites an average IVF success rate of about 65.1% as of 2022, and a 2018 report from Taiwan’s National Health Administration counted 4,883 ART cycles performed at the hospital — the highest cycle volume of any institution in Taiwan that year. These are self-reported, aggregate figures; the hospital does not publish age-specific live-birth tables, so individual outcomes vary with age, ovarian reserve, semen quality and diagnosis. The dedicated international patient team has supported overseas patients for more than 20 years with Mandarin, English and Japanese service. Patient reviews on Google Maps (listing “Maosheng Fertility Center, Lee Women’s Hospital”) show a 4.5-star rating from 2,920 reviews as of September 2026.

The Taichung headquarters integrates obstetrics and pediatrics alongside reproductive medicine, so prenatal care and delivery can continue in-house after a successful pregnancy.

Accreditations & Awards

• CAP accreditation (2025) — the reproductive laboratory was accredited by the College of American Pathologists, a global gold standard for lab quality (hospital milestones page)
• ISO 15189 (2019, extended by TAF in 2025) — genetic and diagnostic laboratory accreditation, covering PGT-A/PGT-M testing, with molecular testing for congenital disease added in the 2025 extension
• Taiwan Hospital Accreditation (2016) — granted by the Ministry of Health and Welfare
• Guinness World Records — 1,232 test-tube babies gathered in one event in 2011; a reunion of 10,000+ IVF-baby families set a second record in 2023 (hospital records)
• National Innovation Award — 2020 (microfluidic chip research with National Yang Ming Chiao Tung University) and 2025 (non-invasive AI embryo-selection study with National Chung Hsing University)
• ASRM recognition — first prize at the 2023 American Society for Reproductive Medicine for analysis of 3,500+ mosaic blastocysts; 7 papers presented at ASRM 2025; 350+ international journal publications overall (hospital milestones page)
• Founder honors — Prof. Lee Mao-Sheng received the 2017 Taiwan Medical Model Award from the Federation of Medical Associations in the Republic of China (Taiwan) and served as a presidential policy advisor (2016-2020)

Why Choose Maosheng Fertility Center

• Four decades of reproductive-medicine depth: from Taiwan’s first locally completed IVF birth in 1987 to one of the country’s highest-volume ART programs (4,883 cycles in 2018, National Health Administration report)
• AI embryo selection at scale: AI imaging has guided embryo selection since 2019, contributing to more than 7,000 reported births through 2023 (hospital milestones page)
• Laboratory quality you can verify: CAP-accredited reproductive lab (2025) plus an ISO 15189/TAF-accredited genetics lab running PGT-A and PGT-M in-house
• Seven core embryo technologies: AI selection, vitrification at -196°C, PGT-M, NGS-based PGT-A, time-lapse imaging (a photo every 10 minutes), spindle imaging under polarized microscopy, and Witness electronic pairing to prevent sample mix-ups
• One-stop maternity care: obstetrics and pediatrics on the same campus, so pregnancy and delivery stay with the same institution
• International-patient experience: a dedicated international medical team with 20+ years of service, Mandarin/English/Japanese coordinators, and patients from 38 countries

IVF & Fertility Services

• In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI)
• Intrauterine Insemination (IUI)
• Preimplantation Genetic Testing: PGT-A chromosome screening by NGS, PGT-M for inherited disease
• Egg freezing (social oocyte freezing, SEF), sperm freezing and embryo freezing by vitrification
• AI-assisted embryo selection and time-lapse embryo monitoring
• Donor egg and donor sperm programs, plus egg and embryo banking, under Taiwan’s Artificial Reproduction Act
• Male infertility evaluation and surgical sperm retrieval
• Female and male infertility work-ups, fertility medication and injection protocols
• Supported by on-site obstetrics, pediatrics, breast surgery, urology, neurology and psychological counseling departments

Fees & Packages

The hospital publishes itemized fees on its official fee page (collected September 2026; TWD converted at roughly NT$32 = US$1). Full IVF cycle packages are not published and require a consultation quote.

Consultations run about NT$250 at the Taichung campus, with partial NHI (national insurance) cost-sharing for infertility-related visits. Taiwan’s National Health Administration operates a public IVF subsidy program (updated scheme effective September 2026), and some cities subsidize elective egg freezing; the international patient team can advise on eligibility. Source: hospital fee page and milestones page.

Patient Journey

1. Inquiry and booking — overseas patients contact the international medical team (WeChat/WhatsApp/email channels listed on the hospital site); appointments at the Taichung headquarters or Banqiao campus are confirmed with your records in advance
2. First-visit evaluation in Taiwan — bring prior charts and test results; the initial visit includes a consultation plus baseline infertility work-up (hormone panel, AMH, ultrasound, semen analysis)
3. Personalized protocol — treatment starts on cycle day 1-3, with ovarian stimulation and ultrasound monitoring in Taichung or Banqiao
4. Retrieval and embryology — ultrasound-guided egg retrieval under the hospital’s pairing-verified Witness system; IVF/ICSI fertilization, time-lapse culture and AI-assisted embryo grading; PGT-A/PGT-M on site when indicated
5. Transfer and pregnancy test — embryo transfer about 3-5 days after retrieval, with a blood pregnancy test roughly two weeks later
6. Prenatal care and follow-up — patients who stay deliver through the hospital’s own obstetrics and pediatrics departments; patients returning home get remote follow-up, with prenatal care continued locally

Local Legal Framework

Assisted reproduction in Taiwan is governed by the Artificial Reproduction Act, regulated by the National Health Administration under the Ministry of Health and Welfare:

• Eligibility: ART (IVF, ICSI, donor insemination, donor egg) is legally restricted to a married man-and-woman couple
• Gamete donation: egg and sperm donation is permitted only through government-approved channels with anonymous, authority-managed matching — recipients may not choose a donor by identity, and donors may not be relatives within the fourth degree of kinship; compensation is capped by law
• Sex selection: embryo sex selection for non-medical reasons is prohibited; PGT-M is allowed to prevent serious hereditary disease
• Surrogacy: commercial and altruistic surrogacy remain illegal under current law; legislative efforts were still in progress as of 2026
• Egg freezing: cryopreserved eggs are limited to a 10-year storage period, renewable, with mandatory reporting to the authorities
• Subsidies: the NHI-administered ART subsidy program offsets part of IVF costs for qualifying couples

Overseas patients should confirm their eligibility (including marriage-certificate requirements) with the international patient center before traveling.

Location

• Address (Taichung HQ): No. 30-6, Sec. 1, Changping Rd., Beitun Dist., Taichung City 40652, Taiwan — about an 8-minute walk from Siwei Elementary School MRT station (from THSR Taichung Station)
• Phone (Taichung HQ): +886-4-2234-7057
• Banqiao Campus (New Taipei): 2F, No. 51, Ln. 188, Sec. 1, Wenhua Rd., Banqiao Dist., New Taipei City 220, Taiwan; phone +886-2-2258-6208 — a 10-minute walk from Banqiao Station on the New Taipei Metro Circular Line